Multimmune Overview

  • Founded
  • 1999
Founded
  • Status
  • Private
  • Latest Deal Type
  • 2ndary - Private
  • Financing Rounds
  • 3

Multimmune General Information

Description

Developer of pharmaceutical products for cancer treatment. The company's technological platform helps in the detection of cell surface-bound heat stock protein 70, Hsp 70, which forms a large proportion of cancer cells but not on healthy cells, enabling the therapist to detect cancer at early stages and to treat cancer cells before they progress into advanced stages.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • C/O Multhoff
  • Kirchenstrasse 82
  • 81675 Munich
  • Germany
+49 089 00000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Multimmune Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Multimmune‘s full profile, request access.

Request a free trial

Multimmune Executive Team (3)

Name Title Board Seat Contact Info
A. Graham Pockley Ph.D Chief Executive Officer
Gabriele Multhoff Ph.D Chief Scientific Officer & Founder
You’re viewing 2 of 3 executive team members. Get the full list »

Multimmune Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Multimmune‘s full profile, request access.

Request a free trial